HIGHLIGHTS
- who: Chengyuan Mao and Yuming Xu from the NorthShore HealthSystem, United States have published the research work: Increased PRR14 and VCAM-1 level in serum of patients with Parkinson`s disease, in the Journal: (JOURNAL)
- what: The authors found that serum levels of Frontiers in Neurology frontiersin.org 10.3389/fneur.2022.993940 Elevated PRR14 and VCAM-1 serum levels among patients with PD reached statistically significant compared with HCs. The studies had some limitations, such as the small sample size (patients with PD and HCs), higher percentages of using antiparkinsonian medication (80%; Table 1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.